Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts (TMCI)
NASDAQ:TMCI
RESEARCH TOOLSreports
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.3Last Year’s EPS
-0.3Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -3.18%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook for Treace Medical, with strong revenue growth and successful product launches being key highlights. Although there were some financial lowlights such as a decrease in gross margin and a net loss for the year, the company's strategic initiatives and improvements in adjusted EBITDA suggest a promising trajectory.Company Guidance
During the fourth quarter 2024 earnings call, Treace Medical Concepts provided guidance for the upcoming year, projecting full-year 2025 revenue in the range of $224 million to $230 million, reflecting an expected growth of 7% to 10% over 2024 revenue. The company anticipates achieving break-even adjusted EBITDA for the year. Fourth quarter 2024 revenue was reported at $68.7 million, a 10.4% increase from the previous year, and full-year 2024 revenue reached $209.4 million, marking a 12% increase over 2023. The gross margin for the fourth quarter was 80.7%, slightly down from 81.6% in the same period of 2023. The company also highlighted the expansion of its product portfolio, including new minimally invasive osteotomy systems, expected to contribute to growth primarily in the latter half of 2025. Treace Medical emphasized its strategy to penetrate the broader market of 4.4 million Americans seeking medical attention for bunions, leveraging its comprehensive suite of specialized solutions.Fourth Quarter Revenue Growth
Treace Medical reported fourth quarter revenue of $68.7 million, a 10.4% increase over the same period in 2023, reaching the top-end of their preliminary results.
Full-Year Revenue Increase
The company reported full-year 2024 revenue of $209.4 million, a 12% increase compared to 2023, achieving the top-end of their guidance.
Successful New Product Launches
Treace Medical successfully introduced new technologies such as Nanoplasty, MicroQuad SpeedPlate, Percuplasty, and IntelliGuide PSI, with positive early feedback from both new and existing surgeon customers.
Significant Adjusted EBITDA Improvement
The company reported a 322% improvement in adjusted EBITDA for the fourth quarter 2024, achieving $11.1 million compared to $2.6 million in 2023.
Expansion of Product Portfolio
Treace Medical expanded its product portfolio with innovative solutions targeting all four classes of bunions, including less invasive options for procedures and the addition of SpeedMTP for arthritic great toe joints.
---
TMCI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TMCI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $9.13 | $8.94 | -2.08% |
| Nov 05, 2024 | $5.76 | $7.78 | +35.07% |
| Aug 06, 2024 | $6.66 | $6.50 | -2.40% |
| May 07, 2024 | $11.12 | $4.17 | -62.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Treace Medical Concepts (TMCI) report earnings?
Treace Medical Concepts (TMCI) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Treace Medical Concepts (TMCI) earnings time?
Treace Medical Concepts (TMCI) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TMCI EPS forecast?
TMCI EPS forecast for the fiscal quarter 2025 (Q1) is -0.3.
---